Lymphocytes subsets after one year of dimethylfumarate treatment in multiple sclerosis: a real life study

Author(s):  
Sara La Gioia
2020 ◽  
Vol 13 (8) ◽  
pp. 100389
Author(s):  
Priscilla Santos ◽  
Gabriela Dias ◽  
Saint Clair Gomes Junior ◽  
Vivian Ruiz ◽  
Fabio Kuschnir ◽  
...  

2015 ◽  
Vol 8 ◽  
pp. A4 ◽  
Author(s):  
Eduardo Costafsilva ◽  
Rogerio Rufino ◽  
Mauricio Bregman ◽  
Denizar Vianna Araújo ◽  
Claudia Costa

2020 ◽  
Vol 26 (1) ◽  
pp. 34-38
Author(s):  
Canan Duman İlki ◽  
Tuncay Gündüz ◽  
Murat Kürtüncü ◽  
Zuhal Yapıcı ◽  
Serra Sencer ◽  
...  

2019 ◽  
Vol 70 (9) ◽  
pp. 3176-3179
Author(s):  
Edwin Sever Bechir ◽  
Mihaela Jana Tuculina ◽  
Mara Carsote ◽  
Marilena Bataiosu ◽  
Mihaela Raescu ◽  
...  

Teriparatide (TPT) (C181H291N55O51S2) represents a recombinant molecule acting as human osteoanabolic agent. Transitory hypercalcemia (TH) has been reported in osteoporotic patients treated with daily TPT. Our purpose is to analyze the biochemical features as well as clinical risk factors for fractures in patients with severe osteoporosis treated with TPT who developed TH during first 12 months. This is an observational real-life study. In patients with TH biochemical blood markers like osteocalcin, CrossLaps and P1NP assessed at one year have statistically significant higher values than in subjects associating serum calcium within normal limits under the drug.


2020 ◽  
Vol 4 (4) ◽  
Author(s):  
Priscilla Filippo Alvim de M. Santos ◽  
Fabio Chigres Kuschnir ◽  
Gabriela Andrade Coelho Dias ◽  
Vivian Pena Ruiz ◽  
Saint Clair Gomes Junior ◽  
...  

2021 ◽  
Vol 429 ◽  
pp. 117773
Author(s):  
Claudia Cutelle' ◽  
Claudia Balducci ◽  
Diletta Cereda ◽  
Maura Frigo ◽  
Maria Letizia Fusco ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document